Wednesday, 26 August 2026European Markets

BARBARA BUI Stock Impressive Rise On Wednesday, Outperforms Market

Loading stream...

(vianews) - the market ended the session with barbara bui (bui.pa) jumping 16.06% to €7.95 on wednesday, after four successive sessions in a row of losses. cac 40 dropped 0.2% to €7,324.76, following the last session's downward trend on what was a somewhat negative trend trading session today.

barbara bui's last close was €6.85, 27.89% below its 52-week high of €9.50.

about barbara bui

barbara bui sa engages in the manufacture, marketing, and sale of ready-to-wear clothing and accessories for women in france and internationally. the company offers jackets, tops and shirts, t-shirts, pants, dresses and skirts, coats, leather products, mesh, and tailored cloths; shoes; bags; and accessories, such as scarves, belts, card holder and key ring, wallets, and jewelries. it offers its products through wholesale distributors, as well as online and offline stores. the company was founded in 1983 and is based in paris, france.

earnings per share

as for profitability, barbara bui has a trailing twelve months eps of €-0.21.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -29.49%.

moving average

barbara bui's worth is higher than its 50-day moving average of €7.76 and above its 200-day moving average of €7.80.

volume

today's last reported volume for barbara bui is 190 which is 533.33% above its average volume of 30.

more news about barbara bui (bui.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com